Table 1.

Frequency of the CHEK2 R95* germline mutation in the Norwegian population

Individuals/patients	R95*-carriersa n	Wild-type n	Total	MAF
Non-cancer individuals	4	3744	3748	5.3 × 10−4
Cancer patients	8	7073	7081	5.6 × 10−4
Breast cancer	4	1713	1717	1.2 × 10−3
Prostate cancer	4	2497	2501	8.0 × 10−4
Lung cancer	0	1331	1331	0
Colorectal cancer	0	1532	1532	0
Total	12	10,817	10,829	5.5 × 10−4

^aAll R95* carriers were heterozygous